Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Vitamin sales in U.S.

This article was originally published in The Tan Sheet

Executive Summary

Vitamin sales in U.S.: Up 11.8% to $2.25 bil. in food, drug and mass merchandise stores for the 52 weeks ending July 20, according to Chicago-based Information Resources, Inc. The largest dollar growth is in mass merchandise outlets, with a 25.4% increase. Dollar sales of mineral supplements are up 26.6% to $852.1 mil., while unit sales increase 20.9% to 140 mil. units. Multivitamin dollar sales rise 3.2% to $696 mil. for the 52 weeks. Mineral supplement sales are strong in each class of trade, with dollar sales increases of 29.1% to $167.8 mil., 15.6% to $432.2 mil. and 49.1% to $252.1 mil. in food, drug and mass merchandise outlets, respectively, according to IRI...

Vitamin sales in U.S.: Up 11.8% to $2.25 bil. in food, drug and mass merchandise stores for the 52 weeks ending July 20, according to Chicago-based Information Resources, Inc. The largest dollar growth is in mass merchandise outlets, with a 25.4% increase. Dollar sales of mineral supplements are up 26.6% to $852.1 mil., while unit sales increase 20.9% to 140 mil. units. Multivitamin dollar sales rise 3.2% to $696 mil. for the 52 weeks. Mineral supplement sales are strong in each class of trade, with dollar sales increases of 29.1% to $167.8 mil., 15.6% to $432.2 mil. and 49.1% to $252.1 mil. in food, drug and mass merchandise outlets, respectively, according to IRI....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel